SENSEX    74339.44       486.50    |    NIFTY    22570.35       167.95 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Hot Pursuit
Scrips, which has significant changes during the market hours for last one week.
Tarsons Products slides after Q1 PAT drops 18% YoY to Rs 20 cr
08-Aug-22   14:51 Hrs IST

Revenue contribution from conventional business in Q1 FY22 was lower due to the demand from other life science industry on account of lockdowns and reduced activities, the company said.

Domestic revenues for Q1 FY23 de-grew by 6% YoY while Exports revenue showed strong resilience and grew by 14% YoY in Q1 FY23.

The company's profit before tax slipped 18.2% to Rs 27.26 crore in the first quarter as against Rs 33.34 crore recorded in the same period last year.

Total expense jumped 16.65% YoY to Rs 44.06 crore in Q1 FY23. Cost of materials consumed was at Rs 17.84 crore (up 9.38% YoY) and employee expenses stood at Rs 8.26 crore (up 8.4% YoY).

EBITDA dropped 15.3% to Rs 31.1 crore in Q1 FY23 as against Rs 36.8 crore posted in Q1 FY22. EBITDA margin declined to 45.4% in Q1 FY23 as compared to 53.2% reported in the corresponding quarter previous year.

EBIDTA margins in Q1 FY23 were impacted on account of higher expenses due to traveling and participation in fare & exhibitions and higher investments in manpower to support future growth.

Commenting on the Q1 FY23 performance of the company Rohan Sehgal, said, “Revenue for Q1 FY23 was muted on account of higher share of Covid related revenues which contributed significantly in Q1 FY22. However, despite negligible contribution from covid related revenues in Q1 FY23 our company has been able to deliver revenues at par on YoY basis. We have been participating in various fare & exhibitions in the exports markets to mark our presence as a leading suppliers of labware products of global standards and quality.”

He further added, “We have been receiving positives responses & enquires and are optimistic of higher demand from international markets going forward. Our expansion of new facilities is on track and progressing well, we believe with the new facilities, addition of new product portfolio and trusted brand for “TARSONS” in the life science community, we are optimistic about the new phase of growth of your company. Our focus remains on brand building, deliver quality products, automation of processes and improve export presence and we continue to work in that direction.”

Tarsons Products is engaged in manufacturing and selling of plastic laboratory products and certain scientific instruments. The company caters to both domestic and international markets.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 88.96 1.07
United Kingdom (GBP) 1.16 1.00 103.28 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.81 83.31 1.00
Market News << ALL News
  25-Apr-2024, (04:33 )  Laurus Lab slides af..
  25-Apr-2024, (04:27 )  Vedanta PAT slides 2..
  25-Apr-2024, (03:45 )  Inox Wind hits recor..
  25-Apr-2024, (03:41 )  Glenmark Life drops ..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)